IBI355

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for IBI355, covering 2024-10-21 to 2025-09-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of IBI355 in Patients With Primary Sjogren's Syndrome [Phase 1]